Covid-19 and work from home in lockdown to prevent infection increased the demand for IT and technology shares. Shares of companies in the pharma sector performed extremely well.
The year 2020 proved to be the best for some mutual funds. This year, mutual funds that invested in pharma, healthcare, technology and international stocks have done extremely well.
Economic Times has analyzed through analysis that 18 funds in these categories have given more than 50 per cent returns this year, while five have given more than 70 per cent returns.
Pharma and technology sector benefit most from Corona infection
The Nifty has given more than 15 per cent returns this time. Fund managers say that after March 23, investors focused on pharma and technology stocks. Funds from other sectors were strongly affected by the economic reversal of the Corona transition but mutual funds investing in technology, healthcare and pharma sector stocks Did quite well.
Work from home increased the demand for IT shares
Covid-19 and work from home in lockdown to prevent infection increased the demand for IT and technology shares. Shares of companies in the pharma sector performed extremely well. Overseas funds investing in foreign stock markets also received good response from investors. Some small and mid-cap funds also took advantage of this. Some such funds also performed well. Analysts say that right now, pharma, healthcare, technology and overseas funds will continue to perform.
Nidhi Malviya is fun loving girl. She writes at NoobFeeds about various topics related to Finance, Technology, Business etc.